The ARDSNet trial used an omega 3 and antioxidant supplement added to "usual" feeding (not any commercially available product). The study stopped for futility. "Futility" means there was no realistic chance that the intervention could be proven to be beneficial with the size trial we had planned. It would not be appropriate to make any conclusions about any other feeding product based upon our study, as it would also be inappropriate to conclude that our treatment was "harmful". The database for our study is not yet locked but once that is done we will be publishing our results which when viewed in their entirety may or may not influence your thinking about this topic.